Darren Simmons - 01 May 2024 Form 4 Insider Report for Everi Holdings Inc. (EVRI)

Role
EVP, FinTech Business Leader
Signature
/s/ Darren D.A. Simmons by Todd A. Valli, Attorney-in-Fact
Issuer symbol
EVRI
Transactions as of
01 May 2024
Net transactions value
-$66,600
Form type
4
Filing time
02 May 2024, 21:34:22 UTC
Previous filing
26 May 2023
Next filing
14 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVRI Common Stock Options Exercise $296,550 +45,000 +29% $6.59 197,550 01 May 2024 Direct F1
transaction EVRI Common Stock Sale $363,150 -45,000 -23% $8.07 152,550 01 May 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVRI Stock Option Options Exercise $0 -45,000 -100% $0.000000* 0 01 May 2024 Common Stock 45,000 $6.59 Direct F3
transaction EVRI Restricted Stock Units Award $0 +39,250 $0.000000 39,250 01 May 2024 Common Stock 39,250 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on September 15, 2023 for options originally granted on May 2, 2014 that would have expired on May 2, 2024.
F2 The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $8.00 to $8.23. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents an option to purchase 45,000 shares of the Company's common stock, which vested in equal installments on each of the first four anniversary dates of the grant
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents restricted stock units to acquire shares of the Company's common stock that will vest in equal installments on each of the first three anniversary dates following the date of grant of May 1, 2024.